Phosphocol P 32 and leukemia
Covidien and Mallinckrodt Inc. informed healthcare professionals of important new safety information in prescribing Phosphocol P 32. Phosphocol P 32
Read MoreFaulty Pharmaceutical Drugs Resources
Covidien and Mallinckrodt Inc. informed healthcare professionals of important new safety information in prescribing Phosphocol P 32. Phosphocol P 32
Read MoreThe FDA has recently received information from the manufacturer about two new cases of progressive multifocal leukoencephalopathy (PML) in patients
Read MoreFDA has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta. Byetta is a medicine
Read MoreFDA is notifying healthcare professionals of the risk of adverse injection site reactions in patients receiving naltrexone (Vivitrol). Physicians should
Read MoreFDA notified healthcare professionals of the risk of muscle injury, rhabdomyolysis, which can lead to kidney failure or death, when
Read MoreEG Labs Announces Urgent Nationwide Voluntary Recall of ALL LOTS of Viapro 375 mg Capsules, due to a Potentially Harmful
Read MoreMerck & Company will begin funding cto resolve state and federal claims over its painkiller Vioxx. The first payment of
Read MoreZyprexa was FDA approved for the short-term treatment of acute manic episodes in bipolar disorder. The worlds best selling schizophrenia
Read MoreArthritis drug Vioxx (Rofecoxib) has been voluntarily recalled by Merck & Co Inc. worldwide. The move to pull the COX-2
Read MoreArthritis drug Vioxx (Rofecoxib) was recalled by Merck & Co., Inc. The Vioxx recall was voluntarily started by Merck to
Read More